Sanofi backs $100M round for startup targeting immune system diseases


Sanofi ADR is throwing its weight behind a new startup that aims to tackle diseases of the immune system with covalent drugs.

Previous Brown Brothers Harriman launches women's networking group
Next LGBTQ provider FOLX Health raises $30M in Series B funding